GYRE
Gyre Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.55
-0.25 ▼ -3.20%
🌙 3월 13일 5:26 PM ET (한국 3/14 06:26)
$7.60
+0.04 ▲ +0.60%
| Index | RUT | P/E | 334.29 | EPS (ttm) | 0.02 | Insider Own | 87.07% | Shs Outstand | 0.09B | Perf Week | -2.01% |
| Market Cap | 0.69B | Forward P/E | - | EPS next Y | 41.94% | Insider Trans | - | Shs Float | 0.01B | Perf Month | -3.76% |
| Enterprise Value | 0.67B | PEG | - | EPS next Q | -0.07 | Inst Own | 3.7% | Short Float | 11.43% | Perf Quarter | -10.7% |
| Income | 0.01B | P/S | 5.89 | EPS this Y | -1650% | Inst Trans | 0.74% | Short Ratio | 14.34 | Perf Half Y | -6.96% |
| Sales | 0.12B | P/B | 6.51 | EPS next 5Y | - | ROA | 3.45% | Short Interest | 1.34M | Perf YTD | 7.01% |
| Book/sh | 1.16 | P/C | 13.1 | EPS past 3/5Y | -63.33% - | ROE | 5.94% | 52W High | -40.13% ($12.62) | Perf Year | -36.83% |
| Cash/sh | 0.58 | P/FCF | - | Sales past 3/5Y | 4.46% 40.96% | ROIC | 4.73% | 52W Low | 23.65% ($6.11) | Perf 3Y | 139.73% |
| Dividend Est. | - | EV/EBITDA | 47.93 | EPS Y/Y TTM | -60.33% | Gross Margin | 95.35% | Volatility(W/M) | 6.69% 6.82% | Perf 5Y | -49.68% |
| Dividend TTM | - | EV/Sales | 5.76 | Sales Y/Y TTM | 10.24% | Oper. Margin | 9.86% | ATR (14) | 0.55 | Perf 10Y | -89.91% |
| Dividend Ex-Date | 2023/1/13 | Quick Ratio | 5.04 | EPS Q/Q | -455.88% | Profit Margin | 4.31% | RSI (14) | 43.12 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.6 | Sales Q/Q | 33.45% | SMA20 | -7.61% ($8.17) | Beta | 1.98 | Target Price | $18.67 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 3000000 | SMA50 | -4.69% ($7.92) | Rel Volume | 1.48 | Prev Close | $7.8 |
| Employees | 625 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -135.27% 4.97% | SMA200 | -2.98% ($7.78) | Avg Volume(3M) | 0.09M | Price | $7.55 |
| IPO | 2006/4/12 | Option/Short | Yes/Yes | Trades | 1220 | Volume | 138,332 | Change | -3.2% |
뉴스 로딩 중...